Androgen receptor–negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms

In prostate cancer, androgen blockade strategies are commonly used to treat osteoblastic bone metastases. However, responses to these therapies are typically brief, and the mechanism underlying androgen-independent progression is not clear. Here, we established what we believe to be the first human...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Li, Zhi Gang, Mathew, Paul, Yang, Jun, Starbuck, Michael W., Zurita, Amado J., Liu, Jie, Sikes, Charles, Multani, Asha S., Efstathiou, Eleni, Lopez, Adriana, Wang, Jing, Fanning, Tina V., Prieto, Victor G., Kundra, Vikas, Vazquez, Elba S., Troncoso, Patricia, Raymond, Austin K., Logothetis, Christopher J., Lin, Sue-Hwa, Maity, Sankar, Navone, Nora M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Clinical Investigation 2008
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2447924/
https://ncbi.nlm.nih.gov/pubmed/18618013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI33093
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg